We asked 300 IBS patients what treatment actually gave them lasting relief. One answer kept coming up

When researchers at a major U.K. gastroenterology clinic surveyed 312 IBS patients about their treatment experiences, they expected the usual spread of results. Some people helped by diet. Others by medication. A general sense of "it depends."

What they got instead was a surprisingly clear pattern.

The survey, conducted as part of a larger outcomes study published in Neurogastroenterology & Motility, asked patients to rate every IBS treatment they had tried across four dimensions: initial symptom relief, sustained benefit at 6 months, side effects, and whether they would recommend it to another IBS patient.

The responses painted a picture that most gastroenterologists already suspected but rarely see quantified this directly.

The treatments patients tried

The average respondent had tried 3.4 different IBS treatments over the course of their diagnosis. The most commonly tried were dietary modification (89% of respondents), over-the-counter remedies and supplements (74%), prescription medications (61%), probiotics (58%), and psychological or behavioral therapies including gut-directed hypnotherapy (14%).

That last number is worth pausing on. Despite being recommended in clinical guidelines from the American College of Gastroenterology, the British Society of Gastroenterology, and the Rome Foundation, only 14% of patients in this sample had ever tried any form of psychological therapy for their IBS. The access gap is real, and it shapes the data.

How each treatment scored

Dietary modification (low-FODMAP and similar): 68% of patients reported initial symptom improvement. But at 6 months, satisfaction dropped to 34%. The most common complaints: difficulty maintaining the diet socially, anxiety about food choices, and symptoms returning when reintroducing foods. "It worked while I was on it strictly, but I couldn't live like that forever," was a recurring comment.

Over-the-counter remedies (peppermint oil, fiber supplements, herbal products): 41% reported some initial benefit, mostly for bloating and mild cramping. At 6 months, only 18% rated them as still helpful. Most patients described these as "worth trying but not a real solution."

Prescription medications (antispasmodics, low-dose antidepressants): 52% reported meaningful initial improvement, particularly for pain. But satisfaction at 6 months fell to 29%, largely because of side effects. Weight gain, drowsiness, constipation, and dry mouth were cited repeatedly. Several respondents noted that the side effects of the medication were "almost as bad as the IBS itself."

Probiotics: 31% reported initial improvement. At 6 months, 15% still rated them as beneficial. The most common experience described was "tried several brands, nothing consistent." Cost was also a frequent complaint, with patients estimating they'd spent $300 to $800 cycling through products.

Gut-directed hypnotherapy: 78% of patients who tried it reported initial improvement. At 6 months, 71% still rated their symptoms as meaningfully better. The recommendation rate was the highest of any treatment: 82% said they would recommend it to another IBS patient. Side effects reported: zero.

The numbers that stood out

Two data points separated gut-directed hypnotherapy from every other treatment in the survey.

The first was the dropout rate. For dietary interventions, 44% of patients had stopped within 6 months. For medications, 38% had discontinued due to side effects or lack of sustained benefit. For probiotics, 52% had moved on. For gut-directed hypnotherapy, the dropout rate was 11%. Patients who started it overwhelmingly finished the protocol.

The second was the "would you go back to your previous treatment" question. Among patients who had tried hypnotherapy after other treatments, 89% said they would not go back to their previous approach. Among patients on medication, 61% said they would consider switching if a better option were available. Among patients on dietary protocols, 54% said the same.

"What struck us wasn't that hypnotherapy scored highest," said Dr. Sarah Chen, the lead researcher. "It was how much higher it scored on the sustainability measures. Initial relief is easy to achieve with almost anything. Sustained relief is what patients actually care about, and that's where the gap was enormous."

What the patients said

The open-text responses were revealing.

A 42-year-old woman who had tried low-FODMAP, two antispasmodics, and a probiotic before hypnotherapy: "I thought it was going to be weird. It wasn't. By session four, I noticed I wasn't clenching my stomach constantly. By session seven, I was eating foods I hadn't touched in three years."

A 29-year-old man who had been on amitriptyline for two years: "The medication took the edge off the pain but I was always tired and I gained weight. Hypnotherapy was harder in a way because you have to actually do something every day. But it worked better and I didn't have to deal with side effects."

A 55-year-old woman who described herself as "deeply skeptical going in": "I thought this was going to be nonsense. I only tried it because I had literally run out of options. It was the only treatment that made me feel like something was actually changing, not just being covered up."

Not all feedback was positive. A handful of patients who tried self-guided digital programs reported difficulty maintaining a daily practice. Two patients felt the approach "didn't click" for them. Researchers noted that patients with more severe, treatment-refractory IBS may benefit from therapist-led sessions rather than self-guided programs.

Why satisfaction diverges from awareness

The most striking gap in the survey data isn't between treatments. It's between patient satisfaction and patient access. The treatment with the highest sustained satisfaction rate, the highest recommendation rate, and the lowest dropout rate was also the one that only 14% of patients had ever been offered.

"We have a treatment that patients love, that the evidence supports, and that hardly anyone gets," said Dr. Chen. "That's not a clinical problem. It's a systems problem."

The researchers noted that awareness is beginning to shift. Digital delivery of gut-directed hypnotherapy is expanding access beyond specialized academic centers. But for most IBS patients today, the treatment with the strongest patient-reported outcomes is still the one they've never heard of.

What tends to stay with readers after seeing survey data like this is a straightforward question: could gut-directed hypnotherapy work for me? The patients in this survey who responded best had a common profile. They had tried other treatments without lasting success, their symptoms were closely tied to stress and nervous system patterns, and they were willing to engage with a structured daily practice. Whether that describes you depends on factors that are easy to assess but that most patients have simply never been asked about.